Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

In response to the increasing interconnectedness of financial service providers across global networks, the BMA is proposing to implement a ...